Vosevi 400mg100mg100mg tablets Royaume-Uni - anglais - MHRA (Medicines & Healthcare Products Regulatory Agency)

vosevi 400mg100mg100mg tablets

gilead sciences international ltd - voxilaprevir; velpatasvir; sofosbuvir - tablet - 100mg ; 100mg ; 400mg

VOSEVI TABLET Canada - anglais - Health Canada

vosevi tablet

gilead sciences canada inc - sofosbuvir; velpatasvir; voxilaprevir - tablet - 400mg; 100mg; 100mg - sofosbuvir 400mg; velpatasvir 100mg; voxilaprevir 100mg - hcv polymerase inhibitors

Vosevi Nouvelle-Zélande - anglais - Medsafe (Medicines Safety Authority)

vosevi

gilead sciences (nz) - sofosbuvir 400mg;  ;  ;  ; velpatasvir 100mg;  ;  ;  ; voxilaprevir 100mg;   - film coated tablet - active: sofosbuvir 400mg       velpatasvir 100mg       voxilaprevir 100mg   excipient: colloidal silicon dioxide copovidone croscarmellose sodium lactose monohydrate magnesium stearate microcrystalline cellulose opadry beige 85f170040 - vosevi is indicated for the treatment of chronic hepatitis c virus (hcv) infection in adults.

EPCLUSA TABLET Canada - anglais - Health Canada

epclusa tablet

gilead sciences canada inc - sofosbuvir; velpatasvir - tablet - 400mg; 100mg - sofosbuvir 400mg; velpatasvir 100mg - hcv polymerase inhibitors

Epclusa 400mg100mg tablets Royaume-Uni - anglais - MHRA (Medicines & Healthcare Products Regulatory Agency)

epclusa 400mg100mg tablets

gilead sciences international ltd - sofosbuvir; velpatasvir - tablet - 400mg ; 100mg

Epclusa Nouvelle-Zélande - anglais - Medsafe (Medicines Safety Authority)

epclusa

gilead sciences (nz) - sofosbuvir 400mg;  ;  ;  ; velpatasvir 100mg;  ;  ;   - tablet - 400mg/100mg - active: sofosbuvir 400mg       velpatasvir 100mg       excipient: copovidone croscarmellose sodium opadry ii pink 85f94644 magnesium stearate microcrystalline cellulose - indicated for the treatment of chronic hepatitis c virus (hcv) infection in adults.